High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-κB and Egr-1

Thrombosis and Haemostasis

Volumn 102, Issue 2, 2009, Pages 352-359

  Lv, Ben ^a,c   Wang, Haichao ^b   Tang, Yiting ^a,c   Fan, Zhang ^a   Xiao, Xianzhong ^c   Chen, Fangping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c Central South University   (China)

Author keywords

Atherosclerosis; HMGB1; Thrombosis; Tissue factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; EARLY GROWTH RESPONSE FACTOR 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; SYNAPTOTAGMIN I; THROMBOPLASTIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR REL; EGR1 PROTEIN, HUMAN; EGR1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE; RAGE PROTEIN, HUMAN; RECOMBINANT PROTEIN; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; TUMOR ANTIGEN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; NUCLEAR LOCALIZATION SIGNAL; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SEPSIS; THROMBOSIS; VASCULAR ENDOTHELIUM; ACTIVE TRANSPORT; ANIMAL; BINDING SITE; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; MUTATION; PROMOTER REGION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, NEOPLASM; BINDING SITES; CELLS, CULTURED; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL CELLS; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-REL; RECOMBINANT PROTEINS; RNA, MESSENGER; THROMBOPLASTIN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 70350448767     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-11-0759     Document Type: Article

References (37)

1. Taubman MB, Fallon JT, Schecter AD, et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997; 78: 200-204.
2. Hatakeyama K, Asada Y, Marutsuka K, et al. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997; 133: 213-219. (Pubitemid 27373498)
3. Annex BH, Denning SM, Channon KM, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622.
4. Chen YJ, Zhang LQ, Wang GP, et al. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells. Thromb Haemost 2008; 100: 291-300.
5. Puhlmann M, Weinreich DM, Farma JM, et al. Interleukin- 1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity. J Transl Med 2005; 3: 37. (Pubitemid 41548698)
6. Bavendiek U, Libby P, Kilbride M, et al. Induction of tissue factor expression in human endothelial cells via CD40 ligand is mediated by AP-1, NF-κB, and Egr-1. J Biol Chem 2002; 277: 25032-25039. (Pubitemid 34951807)
7. Cui MZ, Penn MS, Chisolm GM. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1. J Biol Chem 1999; 274: 32795-32802.
8. Kawano H, Tsuji H, Nishimura H, et al. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Blood 2001; 97: 1697-1702. (Pubitemid 32217236)
9. Steffel J, Akhmedov A, Greutert H, et al. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 2005; 112: 341-349. (Pubitemid 41022074)
10. Cirillo P, De Rosa S, Pacileo M, et al. Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease. J Thromb Haemost 2008; 6: 726-736.
11. Bea F, Puolakkainen MH, McMillen T, et al. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Circ Res 2003; 92: 394-401. (Pubitemid 36298199)
12. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251. (Pubitemid 29329996)
13. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004; 255: 320-331. (Pubitemid 38324549)
14. Porto A, Palumbo R, Pieroni M, et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006; 20: 2565-2576.
15. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377. (Pubitemid 38294612)
16. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195. (Pubitemid 34773774)
17. Qin S, Wang H, Yuan R, et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006; 203: 1637-1642. (Pubitemid 44036267)
18. Tang D, Shi Y, Kang R, et al. Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol 2007; 81: 741-747. (Pubitemid 46393551)
19. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
20. Crisby M, Kallin B, Thyberg J, et al. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 1997; 130: 17-27. (Pubitemid 27158025)
21. Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 1996; 149: 367-380. (Pubitemid 26256326)
22. Levonen AL, Vähäkangas E, Koponen JK, et al. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 2008; 117: 2142-2150. (Pubitemid 351572172)
23. Ito T, Kawahara K, Nakamura T, et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 2007; 5: 109-116. (Pubitemid 44921075)
24. Cai H, Song C, Endoh I, et al. Serum amyloid A induces monocyte tissue factor. J Immunol 2007; 178: 1852-1860. (Pubitemid 46154658)
25. Zhao Y, Zhou S, Heng CK. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27: 1645-1650. (Pubitemid 46986122)
26. Rendon-Mitchell B, Ochani M, Li J, et al. IFN- induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol 2003; 170: 3890-3897. (Pubitemid 36361997)
27. Schabbauer G, Tencati M, Pedersen B, et al. PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice. Arterioscler Thromb Vasc Biol 2004; 24: 1963-1969. (Pubitemid 39350320)
28. Schabbauer G, Schweighofer B, Mechtcheriakova D, et al. Nuclear factor of activated T cells and early growth response-1 cooperate to mediate tissue factor gene induction by vascular endothelial growth factor in endothelial cells. Thromb Haemost 2007; 97: 988-997. (Pubitemid 46939213)
29. Huerta-Zepeda A, Cabello-Gutiérrez C, Cime-Castillo J, et al. Crosstalk between coagulation and inflammation during Dengue virus infection. Thromb Haemost 2008; 99: 936-943. (Pubitemid 351705312)
30. Xin HY, Jiang DJ, Jia SJ, et al. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells. Thromb Haemost 2007; 97: 830-838. (Pubitemid 46779968)
31. Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases - Molecular mechanisms and clinical implications. Circulation 2006; 113: 722-731. (Pubitemid 43754336)
32. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377. (Pubitemid 38294612)
33. Cai H, Song C, Endoh I, et al. Serum amyloid A induces monocyte tissue factor. J Immunol 2007; 178: 1852-1860. (Pubitemid 46154658)
34. Bierhaus A, Illmer T, Kasper M, et al. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 1997; 96: 2262-2271. (Pubitemid 27425832)
35. Kislinger T, Tanji N, Wendt T, et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2001; 21: 905-910. (Pubitemid 34168644)
36. Khachigian LM. Early growth response-1 in cardiovascular pathobiology. Circ Res 2006; 98: 186-191. (Pubitemid 43755349)
37. Du B, Fu C, Kent KC, et al. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-β type II receptor. J Biol Chem 2000; 275: 39039-39047. (Pubitemid 32058917)